artículo académico

• Interaction of Serotonin Transporter (5-HTTLPR) and BDNF (Val66Met) Polymorphisms with Common Mental Disorders in Primary Care Patients.  REVISTA CHILENA DE NEURO-PSIQUIATRIA.  63(3):212-221. 2025
• Association of the 5HTTLPR/rs25531 Genetic Variant with Depression in a Cohort of Primary Care Patients.  REVISTA MEDICA DE CHILE.  152(5):577-588. 2024
• Interaction of Val66Met Brain-Derived Neurotrophic Factor and 5-HTTLPR Serotonin Transporter Gene Polymorphisms with Lifetime Prevalence of Post-Traumatic Stress Disorder in Primary Care Patients.  GENES.  15(11). 2024
• Life and last year prevalence of psychiatric disorders in primary level of care in a region of southern Chile.  GACETA MEDICA ESPIRITUANA.  26:1-14. 2024
• Phase IIa randomized placebocontrolled clinical trial to evaluate the efficacy of bromhexine in combination with standard therapy in the early treatment of COVID-19 in primary care patients.  REVISTA MEDICA DE CHILE.  152(12):1198-1208. 2024
• Interaction of Val66Met BDNF and 5-HTTLPR polymorphisms with prevalence of post-earthquake 27-F PTSD in Chilean population.  PEERJ.  11. 2023
• Peripheral brain-derived neurotrophic factor (BDNF) and salivary cortisol levels in college students with different levels of academic stress. Study protocol.  PLOS ONE.  18(2). 2023
• Bioequivalence Study of Two Hydrochlorothiazide Formulations after Oral Administration in Healthy Chilean Volunteers.  JOURNAL OF PHARMACY AND PHARMACOLOGY (DAVID PUBLISHING).  4(12):679-685. 2016
• Biopsychosocial depression determinants in patients treated in Primary Health Centers at Concepción, Chile.  REVISTA CHILENA DE NEURO-PSIQUIATRIA.  54(2):102-112. 2016
• Association between serotonin transporter and monoamine oxidase A gene polymorphisms and depression.  REVISTA MEDICA DE CHILE.  143:1252-1259. 2015